Stock Scorecard
Stock Summary for T2 Biosystems Inc (TTOO) - $0.35 as of 12/20/2024 9:11:25 PM EST
Total Score
7 out of 30
Safety Score
19 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for TTOO
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for TTOO
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for TTOO
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for TTOO
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for TTOO (19 out of 100)
| Stock Price Rating (Max of 10) | 1 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 6 |
| Price to Earnings (Max of 10) | 0 |
Latest News for for TTOO
Financial Details for TTOO
Company Overview |
|
|---|---|
| Ticker | TTOO |
| Company Name | T2 Biosystems Inc |
| Country | USA |
| Description | T2 Biosystems, Inc., an in vitro diagnostic company, develops diagnostic products and candidate products in the United States and internationally. The company is headquartered in Lexington, Massachusetts. |
| Sector Name | LIFE SCIENCES |
| Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Most Recent Quarter | 9/30/2024 |
| Next Earnings Date | 2/13/2025 |
Stock Price History |
|
| Last Day Price | 0.35 |
| Price 4 Years Ago | 6,200.00 |
| Last Day Price Updated | 12/20/2024 9:11:25 PM EST |
| Last Day Volume | 534,553 |
| Average Daily Volume | 1,016,967 |
| 52-Week High | 8.38 |
| 52-Week Low | 0.31 |
| Last Price to 52 Week Low | 12.90% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 51.82 |
| Sector PE | 40.44 |
| 5-Year Average PE | -90.56 |
| Free Cash Flow Ratio | 3.50 |
| Industry Free Cash Flow Ratio | 33.29 |
| Sector Free Cash Flow Ratio | 27.17 |
| Current Ratio Most Recent Quarter | 0.40 |
| Total Cash Per Share | 0.10 |
| Book Value Per Share Most Recent Quarter | -6.91 |
| Price to Book Ratio | 14.50 |
| Industry Price to Book Ratio | 5.01 |
| Sector Price to Book Ratio | 20.63 |
| Price to Sales Ratio Twelve Trailing Months | 1.03 |
| Industry Price to Sales Ratio Twelve Trailing Months | 12.43 |
| Sector Price to Sales Ratio Twelve Trailing Months | 24.53 |
| Analyst Buy Ratings | N/A |
| Analyst Strong Buy Ratings | N/A |
Share Statistics |
|
| Total Shares Outstanding | 21,043,000 |
| Market Capitalization | 7,365,050 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Last Dividend Amount | 0.00 |
| Current Dividend Amount | 0.00 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 19.23% |
| Reported EPS 12 Trailing Months | -0.03 |
| Reported EPS Past Year | -3.89 |
| Reported EPS Prior Year | -8.30 |
| Net Income Twelve Trailing Months | -42,954,000 |
| Net Income Past Year | -50,077,000 |
| Net Income Prior Year | -62,003,000 |
| Quarterly Revenue Growth YOY | -0.60% |
| 5-Year Revenue Growth | -7.24% |
| Operating Margin Twelve Trailing Months | -4.91 |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 2,083,000 |
| Total Cash Past Year | 15,689,000 |
| Total Cash Prior Year | 10,329,000 |
| Net Cash Position Most Recent Quarter | -9,697,000 |
| Net Cash Position Past Year | -25,459,000 |
| Long Term Debt Past Year | 41,148,000 |
| Long Term Debt Prior Year | 49,496,000 |
| Total Debt Most Recent Quarter | 11,780,000 |
| Equity to Debt Ratio Past Year | -2.14 |
| Equity to Debt Ratio Most Recent Quarter | -167.29 |
| Total Stockholder Equity Past Year | -28,036,000 |
| Total Stockholder Equity Prior Year | -39,655,000 |
| Total Stockholder Equity Most Recent Quarter | -11,710,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -36,644,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -1.74 |
| Free Cash Flow Past Year | -48,328,000 |
| Free Cash Flow Prior Year | -50,968,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.12 |
| MACD Signal | -0.14 |
| 20-Day Bollinger Lower Band | -0.70 |
| 20-Day Bollinger Middle Band | 1.70 |
| 20-Day Bollinger Upper Band | 4.10 |
| Beta | 0.38 |
| RSI | 26.76 |
| 50-Day SMA | 3.51 |
| 150-Day SMA | 339.92 |
| 200-Day SMA | 1,603.81 |
System |
|
| Modified | 12/19/2024 2:04:57 PM EST |